• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用 pH 敏感的聚合物递药系统对化疗药物和 MTH1 抑制剂进行协同治疗用于口腔鳞状细胞癌。

Synergistic therapy of chemotherapeutic drugs and MTH1 inhibitors using a pH-sensitive polymeric delivery system for oral squamous cell carcinoma.

机构信息

Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin 150001, People's Republic of China.

出版信息

Biomater Sci. 2017 Sep 26;5(10):2068-2078. doi: 10.1039/c7bm00395a.

DOI:10.1039/c7bm00395a
PMID:28744533
Abstract

MutT homolog 1 (MTH1) is an essential sanitizer of the free nucleotide pool that prevents lethal DNA damage in cancer cells, which has been validated as an anticancer target in recent years. Small molecule TH287 potently and selectively inhibits the MTH1 protein in cells. Here, we developed an effective chemotherapeutic system for oral squamous cell carcinoma (OSCC) based on polymeric nanoparticles that achieve co-delivery of anticancer drug sodium arsenite (NaAsO) and MTH1 inhibitor TH287. Cationic hyperbranched poly(amine-ester) (HPAE), an amphiphilic and pH-sensitive polymer with a highly branched structure, self-assembled into nanoparticles in aqueous solution. Both NaAsO and TH287 could be loaded into HPAE nanoparticles with the help of electrostatic attraction and hydrophobic interaction. The release of NaAsO and TH287 from HPAE(NaAsO + TH287) nanoparticles was pH-dependent. In vitro evaluation demonstrated that the HPAE(NaAsO + TH287) nanoparticles rapidly entered cancer cells and released NaAsO and TH287 in response to acidic intracellular environments. In comparison with NaAsO, TH287, HPAE(NaAsO) nanoparticles, HPAE(TH287) nanoparticles, and the physical mixture of HPAE(NaAsO) nanoparticles and TH287, the HPAE(NaAsO + TH287) nanoparticles exhibited more effective inhibition of tumor cell proliferation, illustrating the synergistic effect of NaAsO and TH287. The experimental results show that TH287 is likely to inhibit MTH1 in tumor cells, rendering them more sensitive to NaAsO.

摘要

MutT 同源物 1(MTH1)是游离核苷酸池的必需净化剂,可防止癌细胞中的致命 DNA 损伤,近年来已被验证为抗癌靶标。小分子 TH287 可有效且选择性地抑制细胞中的 MTH1 蛋白。在这里,我们基于聚合纳米颗粒开发了一种有效的口腔鳞状细胞癌(OSCC)化疗系统,该系统可实现抗癌药物亚砷酸钠(NaAsO)和 MTH1 抑制剂 TH287 的共递药。阳离子超支化聚(胺-酯)(HPAE)是一种具有高度支化结构的两亲性和 pH 敏感聚合物,在水溶液中自组装成纳米颗粒。在静电吸引和疏水相互作用的帮助下,NaAsO 和 TH287 都可以负载到 HPAE 纳米颗粒中。HPAE(NaAsO + TH287)纳米颗粒中 NaAsO 和 TH287 的释放与 pH 有关。体外评价表明,HPAE(NaAsO + TH287)纳米颗粒迅速进入癌细胞,并在响应酸性细胞内环境时释放出 NaAsO 和 TH287。与 NaAsO、TH287、HPAE(NaAsO)纳米颗粒、HPAE(TH287)纳米颗粒和 HPAE(NaAsO)纳米颗粒与 TH287 的物理混合物相比,HPAE(NaAsO + TH287)纳米颗粒对肿瘤细胞增殖的抑制作用更有效,说明 NaAsO 和 TH287 具有协同作用。实验结果表明,TH287 可能会抑制肿瘤细胞中的 MTH1,使它们对 NaAsO 更敏感。

相似文献

1
Synergistic therapy of chemotherapeutic drugs and MTH1 inhibitors using a pH-sensitive polymeric delivery system for oral squamous cell carcinoma.利用 pH 敏感的聚合物递药系统对化疗药物和 MTH1 抑制剂进行协同治疗用于口腔鳞状细胞癌。
Biomater Sci. 2017 Sep 26;5(10):2068-2078. doi: 10.1039/c7bm00395a.
2
Delivery of MTH1 inhibitor (TH287) and MDR1 siRNA via hyaluronic acid-based mesoporous silica nanoparticles for oral cancers treatment.基于透明质酸的介孔硅纳米粒子递送 MTH1 抑制剂(TH287)和 MDR1 siRNA 用于口腔癌治疗。
Colloids Surf B Biointerfaces. 2019 Jan 1;173:599-606. doi: 10.1016/j.colsurfb.2018.09.076. Epub 2018 Sep 29.
3
Delivery of MutT homolog 1 inhibitor by functionalized graphene oxide nanoparticles for enhanced chemo-photodynamic therapy triggers cell death in osteosarcoma.功能化氧化石墨烯纳米颗粒递送 MutT 同源物 1 抑制剂增强化疗-光动力疗法触发骨肉瘤细胞死亡。
Acta Biomater. 2020 Jun;109:229-243. doi: 10.1016/j.actbio.2020.04.009. Epub 2020 Apr 12.
4
MTH1 Inhibitor TH287 Suppresses Gastric Cancer Development Through the Regulation of PI3K/AKT Signaling.MTH1 抑制剂 TH287 通过调节 PI3K/AKT 信号通路抑制胃癌发展。
Cancer Biother Radiopharm. 2020 Apr;35(3):223-232. doi: 10.1089/cbr.2019.3031. Epub 2020 Feb 20.
5
Sequential release of autophagy inhibitor and chemotherapeutic drug with polymeric delivery system for oral squamous cell carcinoma therapy.用于口腔鳞状细胞癌治疗的聚合物递送系统对自噬抑制剂和化疗药物的顺序释放
Mol Pharm. 2014 May 5;11(5):1662-75. doi: 10.1021/mp5000423. Epub 2014 Apr 4.
6
Radiolabeled 6-(2, 3-Dichlorophenyl)-N4-methylpyrimidine-2, 4-diamine (TH287): A Potential Radiotracer for Measuring and Imaging MTH1.放射性标记的 6-(2,3-二氯苯基)-N4-甲基嘧啶-2,4-二胺(TH287):一种用于测量和成像 MTH1 的潜在放射性示踪剂。
Int J Mol Sci. 2020 Nov 23;21(22):8860. doi: 10.3390/ijms21228860.
7
MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool.MTH1 抑制通过防止 dNTP 池的清洁来消除癌症。
Nature. 2014 Apr 10;508(7495):215-21. doi: 10.1038/nature13181. Epub 2014 Apr 2.
8
Augment of Oxidative Damage with Enhanced Photodynamic Process and MTH1 Inhibition for Tumor Therapy.增强光动力过程和 MTH1 抑制的氧化损伤用于肿瘤治疗。
Nano Lett. 2019 Aug 14;19(8):5568-5576. doi: 10.1021/acs.nanolett.9b02112. Epub 2019 Jul 5.
9
MTH1 deficiency selectively increases non-cytotoxic oxidative DNA damage in lung cancer cells: more bad news than good?MTH1 缺乏选择性增加肺癌细胞中非细胞毒性氧化 DNA 损伤:弊大于利?
BMC Cancer. 2018 Apr 16;18(1):423. doi: 10.1186/s12885-018-4332-7.
10
Antitumor effects of MutT homolog 1 inhibitors in human bladder cancer cells.MutT同源物1抑制剂对人膀胱癌细胞的抗肿瘤作用。
Biosci Biotechnol Biochem. 2019 Dec;83(12):2265-2271. doi: 10.1080/09168451.2019.1648207. Epub 2019 Jul 31.

引用本文的文献

1
Innovative nanoparticle strategies for treating oral cancers.治疗口腔癌的创新纳米颗粒策略。
Med Oncol. 2025 Apr 26;42(6):182. doi: 10.1007/s12032-025-02728-y.
2
TEAD transcription factor family emerges as a promising therapeutic target for oral squamous cell carcinoma.TEAD 转录因子家族成为口腔鳞状细胞癌有前途的治疗靶点。
Front Immunol. 2024 Oct 4;15:1480701. doi: 10.3389/fimmu.2024.1480701. eCollection 2024.
3
Targeting MutT Homolog 1 (MTH1) for Breast Cancer Suppression by Using a Novel MTH1 Inhibitor MA-24 with Tumor-Selective Toxicity.
通过使用具有肿瘤选择性毒性的新型MTH1抑制剂MA-24靶向MutT同源物1(MTH1)来抑制乳腺癌
Pharmaceuticals (Basel). 2024 Feb 23;17(3):291. doi: 10.3390/ph17030291.
4
Current trends of targeted therapy for oral squamous cell carcinoma.口腔鳞状细胞癌靶向治疗的现状。
J Cancer Res Clin Oncol. 2022 Sep;148(9):2169-2186. doi: 10.1007/s00432-022-04028-8. Epub 2022 May 2.
5
5FU encapsulated polyglycerol sebacate nanoparticles as anti-cancer drug carriers.5-氟尿嘧啶包封的聚癸二酸甘油酯纳米颗粒作为抗癌药物载体
RSC Adv. 2021 May 25;11(31):18984-18993. doi: 10.1039/d1ra01722e. eCollection 2021 May 24.
6
Nanoparticles in Dentistry: A Comprehensive Review.牙科中的纳米颗粒:全面综述
Pharmaceuticals (Basel). 2021 Jul 30;14(8):752. doi: 10.3390/ph14080752.
7
Nanoparticles for Oral Cancer Diagnosis and Therapy.用于口腔癌诊断与治疗的纳米颗粒
Bioinorg Chem Appl. 2021 Apr 23;2021:9977131. doi: 10.1155/2021/9977131. eCollection 2021.
8
The Benefits of Smart Nanoparticles in Dental Applications.智能纳米颗粒在牙科应用中的益处。
Int J Mol Sci. 2021 Mar 4;22(5):2585. doi: 10.3390/ijms22052585.
9
Stimuli-responsive drug delivery systems for head and neck cancer therapy.用于头颈部癌症治疗的刺激响应型药物输送系统。
Drug Deliv. 2021 Dec;28(1):272-284. doi: 10.1080/10717544.2021.1876182.
10
Current Trends of Targeted Drug Delivery for Oral Cancer Therapy.口腔癌治疗中靶向药物递送的当前趋势
Front Bioeng Biotechnol. 2020 Dec 8;8:618931. doi: 10.3389/fbioe.2020.618931. eCollection 2020.